Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2011 4
2012 2
2013 1
2014 1
2016 1
2017 1
2018 2
2019 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.
Krueger JG, Wharton KA Jr, Schlitt T, Suprun M, Torene RI, Jiang X, Wang CQ, Fuentes-Duculan J, Hartmann N, Peters T, Koroleva I, Hillenbrand R, Letzkus M, Yu X, Li Y, Glueck A, Hasselberg A, Flannery B, Suárez-Fariñas M, Hueber W. Krueger JG, et al. Among authors: letzkus m. J Allergy Clin Immunol. 2019 Sep;144(3):750-763. doi: 10.1016/j.jaci.2019.04.029. Epub 2019 May 24. J Allergy Clin Immunol. 2019. PMID: 31129129 Free article. Clinical Trial.
Robust and tissue-independent gender-specific transcript biomarkers.
Staedtler F, Hartmann N, Letzkus M, Bongiovanni S, Scherer A, Marc P, Johnson KJ, Schumacher MM. Staedtler F, et al. Among authors: letzkus m. Biomarkers. 2013 Aug;18(5):436-45. doi: 10.3109/1354750X.2013.811538. Epub 2013 Jul 8. Biomarkers. 2013. PMID: 23829492
Perturbation of microRNAs in rat heart during chronic doxorubicin treatment.
Vacchi-Suzzi C, Bauer Y, Berridge BR, Bongiovanni S, Gerrish K, Hamadeh HK, Letzkus M, Lyon J, Moggs J, Paules RS, Pognan F, Staedtler F, Vidgeon-Hart MP, Grenet O, Couttet P. Vacchi-Suzzi C, et al. Among authors: letzkus m. PLoS One. 2012;7(7):e40395. doi: 10.1371/journal.pone.0040395. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22859947 Free PMC article.
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
Torene R, Nirmala N, Obici L, Cattalini M, Tormey V, Caorsi R, Starck-Schwertz S, Letzkus M, Hartmann N, Abrams K, Lachmann H, Gattorno M. Torene R, et al. Among authors: letzkus m. Ann Rheum Dis. 2017 Jan;76(1):303-309. doi: 10.1136/annrheumdis-2016-209335. Epub 2016 Jul 29. Ann Rheum Dis. 2017. PMID: 27474763 Free PMC article. Clinical Trial.
A microarray analysis of full depth knee cartilage of ovariectomized rats.
Bay-Jensen AC, Nielsen RH, Segovia-Silvestre T, Azria M, Staedtler F, Letzkus M, Hartmann N, Brachat AH, Karsdal MA. Bay-Jensen AC, et al. Among authors: letzkus m. BMC Res Notes. 2011 Mar 15;4:63. doi: 10.1186/1756-0500-4-63. BMC Res Notes. 2011. PMID: 21406075 Free PMC article.
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled study.
Metz M, Torene R, Kaiser S, Beste MT, Staubach P, Bauer A, Brehler R, Gericke J, Letzkus M, Hartmann N, Erpenbeck VJ, Maurer M. Metz M, et al. Among authors: letzkus m. Allergy. 2019 Jan;74(1):141-151. doi: 10.1111/all.13547. Epub 2018 Oct 15. Allergy. 2019. PMID: 29974963 Clinical Trial.
15 results